Literature DB >> 13750

Selectivity of clenbuterol (NAB 365) in guinea-pig isolated tissues containing beta-adrenoceptors.

S R O'Donnell.   

Abstract

The effects of clenbuterol (ANB 365), an aminohalogen substituted phenylethanolamine, have been examined on isolated tissue preparations from guinea-pigs. Clenbuterol produced concentration (or dose)-dependent relaxations of tracheal chains, decreases in perfusion pressure of hind limb blood vessels, inhibitions of acetylcholine-induced contractions of the uterus, increases in atrial rate and inhibitions of electrically-induced contractions of the ileum. These responses were blocked by propranolol. Clenbuterol was similar in potency to isoprenaline on the trachea (carbachol-contracted), hind limb and uterus (beta2-adrenoceptors) but was significantly less potent than isoprenaline on the atria and the ileum (beta1-adrenoceptors). Clenbuterol produced marked relaxation of intrinsic tone tracheal preparations in concentrations up to 3000 times less than were required on carbachol-contracted preparations, whereas for isoprenaline the concentrations required on intrinsic tone preparations were only 55 fold less. It is concluded that clenbuterol is a beta-adrenoceptor agonist and that it is a partial agonist on the carbachol-stimulated trachea, on the atria and on hind limb blood vessels. It shows beta2-selectivity in that its potency, relative to that of isoprenaline, on the preparations containing beta2-adrenoceptors was much higher than on those with beta1-adrenoceptors. On intrinsic tone tracheal preparations it may produce an additional relaxant effect responsible for its high potency on that preparation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 13750

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  7 in total

1.  Tocolytic drugs for use in veterinary obstetrics.

Authors:  L Ménard
Journal:  Can Vet J       Date:  1984-10       Impact factor: 1.008

Review 2.  On the action of combination bronchodilators.

Authors:  C J Hanna; P Eyre
Journal:  Agents Actions       Date:  1979-10

3.  Potential anti-anaphylactic activity of clenbuterol, a beta-agonist with calcium antagonist properties.

Authors:  N Frossard; J C Frankhuyzen-Sierevogel; M Binck; J Noordhoek; Y Landry
Journal:  Agents Actions       Date:  1985-04

4.  Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on beta 2-adrenoceptor density in female rats.

Authors:  M N Sillence; M L Matthews; W G Spiers; G G Pegg; D B Lindsay
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

5.  Ractopamine-induced fiber type-specific gene expression in porcine skeletal muscles is independent of growth.

Authors:  Andrea M Gunawan; Con-Ning Yen; Brian T Richert; Allan P Schinckel; Alan L Grant; David E Gerrard
Journal:  J Anim Sci       Date:  2020-11-01       Impact factor: 3.159

6.  Analysis of the beta 1 and beta 2 adrenoceptor interactions of the partial agonist, clenbuterol (NAB365), in the rat jugular vein and atria.

Authors:  M L Cohen; K S Wiley; K G Bemis
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-08       Impact factor: 3.000

7.  Prediction of the therapeutic dose for beta-stimulants based on preclinical data: application of oral dosage forms and aerosols to asthmatic patients.

Authors:  K Ito; N Yajima; H Ohtani; Y Yamada; K Nakamura; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1993-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.